Top courses that will set you apart from your peers.
The Accelerator Track is designed for academically driven students to introduce them to the rigors of medical science. This program emphasizes on advanced concepts and incorporates recent scientific developments, discoveries, technological advancements in biomedical science, and enables students to delve deeper into the real world applications.
Students in the program undertake guided scientific projects and engage in meaningful research questions. They also have the opportunity to present their findings at scientific symposiums and competitions, gaining firsthand experience of the real-world impact their work can achieve.
Students: High School / Middle School / Gap year students
Duration: Two Weeks (between 9AM - 5PM Pacific Time, approximately 5-6 hours/day )
Skill Level: Beginner to Advanced
Program Dates: T.B.A
Format: Online
Courses Offered: Refer Here
Note: The exact schedule may vary slightly to accommodate instructor availability and student-cohort needs.
No prior AP Biology or advanced knowledge is required. The course begins with an introduction to foundational concepts, ensuring that all students are well-prepared for in-depth research.
Interactive discussions based on key literature and publications help students identify core questions and demonstrate systematic, scientific approaches to problem-solving. These sessions encourage collaboration, critical thinking, and deeper engagement with the material.
As part of the program, students embark on guided scientific projects, selecting a topic of their choice from the subjects covered in the course. Instructors work closely with students to identify relevant scientific literature, enabling the formulation of valid hypotheses and fostering independent research skills.
Individualized sessions with instructors provide students the opportunity for discussion spanning their research, academic interests and aspirations. These meetings help explore potential college majors, elective subjects, and career prospects that align with their goals.
Course Name
Code
Genetics & Cancer Biology
AT-011
Neuroscience
AT-015
Biotechnology
AT-017
Biomed Data Science
AT-020
Immunology
AT-022
Biomedical Chemistry & Pharmacology
AT-055
https://elioacademy.org/harshita-sinha-and-yaanaa-garg
Group 3 medulloblastoma is among the most aggressive form of pediatric brain tumors. Our research looks at why it has one of the most survival rates and what the the genetic drivers of it. We found the PI3K/mTOR pathway that is fueling autophagy and making the tumor treatment resistance . We studied the drug Bimiralisib that could potentially overcome this treatment resistance when combined with craniospinal irradiation, kill the tumor.
https://elioacademy.org/kayla-roh-and-tarun-chethan
ALS is a fatal neurodegenerative disorder, leads to the degeneration of motor neurons, resulting in muscle weakness, loss of motor control, and eventual respiratory failure. The study focuses on the interactions between the SOD1 gene and proteins CCS (Copper Chaperone for Superoxide Dismutase) and Superoxide Dismutase 2
https://elioacademy.org/jacob-shachar-and-raj-datta
Spinal Muscular Atrophy (SMA) is a genetically inherited neurodegenerative disorder caused by a mutation of the Survival Motor Neuron 1 (SMN1) gene. SMN1 codes for the Survival of Motor Neuron (SMN) protein. If we use BCI to inhibit Dual-Specificity Phosphatase 1/6, then we can mitigate several effects of SMA when combined with SMA gene therapy because DUSP1/6 inhibit regulatory proteins in the Mitogen-activated protein kinase (MAPK) signaling pathway.
https://elioacademy.org/regina-huang
TP53 germline mutations are the main factors causing Li-Fraumeni Syndrome (LFS), an infrequent cancer predisposition pathology. Up to ninety percent of patients with this syndrome develop malignancies within their lives, mostly at an earlier age. The tumor suppressor protein, p53, encoded by TP53, takes part in controlling several critical pathways, including cell-cycle regulation, DNA repair, apoptosis, and genomic stability.
https://elioacademy.org/connor-chiu
Glioblastoma (GBM) is the most common primary malignant brain cancer, accounting for about 50% of all primary brain cancers, and is characterized by its highly aggressive nature, poor prognosis, and low survival rate. Each year, it is the cause of over 15,000 deaths in the United States, with the five-year survival rate for patients being about 5% and the average survival length estimated to be only 12-18 months.

Apply to ELIO mentored projects in Genetics, Neuroscience, Medical Data Science, Biochemistry (Click Here)
Get access to handpicked opportunities and resources!